Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Curis, Inc.

Clinical trials sponsored by Curis, Inc., explained in plain language.

Curis, Inc. CRIS NASDAQ

Develops targeted cancer therapies.

Trade on eToro (ad)

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Trials to join now! 2 Not yet finished but already full! 1

New pill shows promise for Hard-to-Treat blood cancers

Disease control Terminated

This study tests an oral drug called emavusertib (CA-4948) in adults with acute myeloid leukemia (AML) or a high-risk bone marrow disorder (MDS) that have not responded to or returned after prior treatment. The goal is to find the safest and most effective dose and to see if the …

Phase: PHASE1, PHASE2 • Sponsor: Curis, Inc. • Aim: Disease control

Last updated Jun 27, 2026 11:03 UTC